ASTHMA AND ALLERGY CENTER, P.A. Home About Linda Cox Publications Directions Videos Privacy
Linda S. Cox, M.D., FAAAI, FACAAI ACP
Linda S. Cox, MD - (954) 771-0928 Home About Linda Cox Publications Directions Videos Privacy Publications Publications
Copyright (c) 2016 by Allergy & Asthma Center - Fort Lauderdale - Florida
LIST OF PUBLICATIONS Articles/Abstracts 1. Experience with Accelerated Immunotherapy Schedules Utilizing Multiple and Single Allergen Extracts in a Private Practice Setting. Abstract  ACAAI  1996 2. Borish, L, Dishuck J,Cox, L  Sezary syndrome with elevated serum IgE and hypereosinophilia: Role of dysregulated cytokine production. J Allergy Clin Immunol. 1993 Jul;92(1 Pt 1):123-31. 3. Chapter 41 entitiled   Instruction and Consent Forms For Allergen Immunotherapy. Lockey Rf BS, Bousquet J (eds). Allergens and allergen immunotherapy. third ed. New York & Basel: MARCEL DEKKER, INC; 2004. 4. Cox, L Better documentation through standardized forms. What progress have we   made since the 1800s Allergy and Asthma Proc 24: 407-422, 2004 5. Carr, W, Martin, B,  Howard, B, Cox, L,  Borish,L  and the Immunotherapy Committee of the American Academy of Allergy, Asthma and Immunology Comparison of test devices for skin prick testing (J Allergy Clin Immunol 2005;116:341-6.) 6. Amin HS, Liss GM, Bernstein DI. and the Immunotherapy Committee of the American Academy of Allergy, Asthma and Immunology Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol. 2006 Jan;117(1):169-75 7. Cox, L Standardized allergen extracts: past, present and future Expert Review of Clinical Immunology, Nov 2005, Vol. 1, No. 4, Pages 579-588. 8. Cox L, Larenas-Linnemann D, Nolte H, Weldon D, Finegold I, Nelson H Sublingual Immunotherapy: A Comprehensive Review J Allergy Clin Immunol. 2006;117:1021-35 9. Cox, L Allergen immunotherapy: immunomodulatory treatment for allergic diseases Expert Review of Clinical Immunology, Jul 2006, Vol. 2, No. 4, Pages 533-546. 10. Cox, L Accelerated immunotherapy schedules: review of efficacy and safety. Ann Allergy Asthma Immunol. 2006 Aug;97(2):126-37; quiz 137-40, 202. Review. 11. Cox L, Cohn JR. Duration of allergen immunotherapy in respiratory allergy: when is enough, enough? Ann Allergy Asthma Immunol 2007;98:416-26. 12. Cox L LJ, Nelson H, Lockey R. Allergen immunotherapy: A practice parameter second update. The Journal of Allergy and Clinical Immunology 2007;120:S25-S85 13. Cox L,Platts-Mills T, Finegold I et.al. ACAAI Joint Task Force Report on Omalizumab-Associated Anaphylaxis J Allergy Clin Immunol.2007;in press 14. Cox, L Sublingual Immunotherapy in PediatricAllergic Rhinitis and Asthma: Efficacy,Safety, and Practical ConsiderationsCurr Allergy Asthma Rep 2007;7:410-20 15. Larenas-Linnemann DE, Cox LS. Sublingual immunotherapy for asthma: need for high quality meta-analyses to prove the concept. Allergy 2007; 62:704-5; author reply 6-7. 16. Hankin CS, Cox L, Lang D, Levin A, Gross G, Eavy G, et al. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs. J Allergy Clin Immunol 2008; 121:227-32. 17. Cox L. Sublingual immunotherapy and allergic rhinitis. Curr Allergy Asthma Rep 2008; 8:102-10. 18. Larenas-Linnemann D, Cox LS. European allergen extract units and potency: review of available information. Ann Allergy Asthma Immunol 2008; 100:137-45. 19. Cox L. Advantages and disadvantages of accelerated immunotherapy schedules. J Allergy Clin Immunol 2008; 122:432-4. 20. Cox L. Allergen immunotherapy and asthma: Efficacy, safety, and other considerations. Allergy Asthma Proc 2008;29:580-9. 21. Cox L, Williams B, Sicherer S, et al. Pearls and pitfalls of allergy diagnostic testing: report from the American College of Allergy, Asthma and Immunology/American Academy of Allergy, Asthma and Immunology Specific IgE Test Task Force. Ann Allergy Asthma Immunol 2008;101:580-92. 22. Casale TB, Canonica GW, Bousquet J, Cox L, et al. Recommendations for appropriate sublingual immunotherapy clinical trials. J Allergy Clin Immunol 2009;124:665-70. 23. Cox LS. How safe are the biologicals in treating asthma and rhinitis? Allergy Asthma Clin Immunol 2009;5:4. 24. Cox L, Jocobsen L. Comparison of allergen immunotherapy practice patterns in the United States and Europe. Ann Allergy Asthma Immunol. 2009;103: 451–460. 25. Bousquet PJ, Cox LS, Durham SR, et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009;64 Suppl 91:1-59. 26. Hankin CS, Cox L, Lang D, et al. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study. Ann Allergy Asthma Immunol 2010;104:79-85. 27. Cox L, Larenas D, Lockey R, Passalacqua G. Speaking the Same Language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. . J Allergy Clin Immunol 125(3): 569-574, 574 e561-574 e567 28. Cox L, Calderon MA. Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe. Curr Med Res Opin 2010;26:2723-33 29. Cox L, Compalati E, Canonica W. Will Sublingual Immunotherapy Become an Approved Treatment Method in the United States? Curr Allergy Asthma Rep 2010. 30. Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: A practice parameter third update. J Allergy Clin Immunol 2010.